Cargando…

A cancer‐associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss‐of‐function

CDKN1B haploinsufficiency promotes the development of several human cancers. The gene encodes p27(Kip1), a protein playing pivotal roles in the control of growth, differentiation, cytoskeleton dynamics, and cytokinesis. CDKN1B haploinsufficiency has been associated with chromosomal or gene aberratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bencivenga, Debora, Stampone, Emanuela, Aulitto, Arianna, Tramontano, Annunziata, Barone, Clementina, Negri, Aide, Roberti, Domenico, Perrotta, Silverio, Della Ragione, Fulvio, Borriello, Adriana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024736/ https://www.ncbi.nlm.nih.gov/pubmed/33316141 http://dx.doi.org/10.1002/1878-0261.12881

Ejemplares similares

High Dosage Lithium Treatment Induces DNA Damage and p57(Kip2) Decrease
por: Stampone, Emanuela, et al.
Publicado: (2020)

A Beckwith–Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57(Kip2)
por: Stampone, Emanuela, et al.
Publicado: (2021)

p27(Kip1), an Intrinsically Unstructured Protein with Scaffold Properties
por: Bencivenga, Debora, et al.
Publicado: (2021)

Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
por: Stampone, Emanuela, et al.
Publicado: (2023)

Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions
por: Borriello, Adriana, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation
por: Borriello, Adriana, et al.
Publicado: (2016)

Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases
por: Stampone, Emanuela, et al.
Publicado: (2018)

The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells
por: Borriello, Adriana, et al.
Publicado: (2011)

An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs
por: Bencivenga, Debora, et al.
Publicado: (2022)

Hypocalcemia: A key biomarker in hospitalized COVID-19 patients
por: Ruiz-Álvarez, María Jesús, et al.
Publicado: (2023)

Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
por: Campana, Pasquale, et al.
Publicado: (2020)

Regulation of p27(Kip1) and p57(Kip2) Functions by Natural Polyphenols
por: Russo, Gian Luigi, et al.
Publicado: (2020)

EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34(+) Cell Differentiation and Increases Circulating Endothelial Precursors
por: Perrotta, Silverio, et al.
Publicado: (2010)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies
por: Santoro, Claudia, et al.
Publicado: (2014)

MIR-491: CDKN2A tumor suppressor co-pilot
por: Moore, Lynette M., et al.
Publicado: (2015)

Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene
por: Punzo, Francesca, et al.
Publicado: (2011)

MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer
por: Zhu, Changyu, et al.
Publicado: (2023)

CDKN1C/p57(kip2 )is a candidate tumor suppressor gene in human breast cancer
por: Larson, Pamela S, et al.
Publicado: (2008)

Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors
por: Minervini, Giovanni, et al.
Publicado: (2017)

Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance
por: Yang, Chenlong, et al.
Publicado: (2020)

SDPS-27 P16 IMMUNOHISTOCHEMISTRY AS A SCREENING TOOL FOR HOMOZYGOUS CDKN2A DELETIONS IN GLIAL TUMORS
por: Zschernack, Valentina, et al.
Publicado: (2023)

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors
por: Algar, Elizabeth M., et al.
Publicado: (2009)

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma
por: Yu, Yang, et al.
Publicado: (2018)

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas
por: Iolascon, A, et al.
Publicado: (2000)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Methylation Analysis of Several Tumour Suppressor Genes Shows a Low Frequency of Methylation of CDKN2A and RARB in Uveal Melanomas
por: Zeschnigk, Michael, et al.
Publicado: (2003)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity
por: Roberti, Domenico, et al.
Publicado: (2018)

CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system—New mode of action for caffeine
por: Ale-Agha, Niloofar, et al.
Publicado: (2018)

CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter
por: Qiu, Zhengang, et al.
Publicado: (2019)

miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition
por: Huang, Shirui, et al.
Publicado: (2021)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
por: Torre, G Della, et al.
Publicado: (2001)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

E47 Governs the MYC-CDKN1B/p27(KIP1)-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16(INK4A) and Wild-Type p53
por: Scully, Kathleen M., et al.
Publicado: (2018)

Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis
por: SIRMA, HÜSEYIN, et al.
Publicado: (2013)

RF27 | LBSUN362 Germline CDKN1B Variants Type And Site Are Associated With Specific Phenotype In Multiple Endocrine Neoplasia 4
por: Halperin, Reut, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02j2cokk69t2ogl1gi07fslps6